Briefing
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities
After a complete clinical response to first-line therapy, surgically detected MRD on second-look laparoscopy (40/95, 42.1%) and ctDNA positivity (15/44, 34%) were each associated with shorter PFS and OS; SLL positivity was independently associated with OS (HR 4.40).
- Design: Evidence level 2
- Assay: Not named in the abstract
Clin Cancer ResPubMed 40748258DOI 10.1158/1078-0432.CCR-25-0512